Clinical findings and lung pathology in children with cystic fibrosis, Am J Respir Crit Care Med, vol.165, pp.1172-1175, 2002. ,
DOI : 10.1164/ajrccm.165.8.2104090
Cystic fibrosis in adults: current and future management strategies, Clin Rev Allergy Immunol, vol.25, pp.275-287, 2003. ,
DOI : 10.1385/criai:25:3:275
CFTR function and prospects for therapy, Annu Rev Biochem, vol.77, pp.701-726, 2008. ,
DOI : 10.1146/annurev.biochem.75.103004.142532
The biophysics, biochemistry and physiology of CFTR, Cell Mol Life Sci, vol.74, pp.1-2, 2017. ,
Cystic fibrosis: a clinical view, Cell Mol Life Sci, vol.74, pp.129-140, 2017. ,
Cystic fibrosis infections: treatment strategies and prospects, FEMS Microbiol Lett, vol.300, pp.153-164, 2009. ,
DOI : 10.1111/j.1574-6968.2009.01704.x
Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life, Am J Respir Crit Care Med, vol.183, pp.1463-1471, 2011. ,
Managing Pseudomonas aeruginosa respiratory infections in cystic fibrosis, Curr Opin Infect Dis, vol.28, pp.547-556, 2015. ,
DOI : 10.1097/qco.0000000000000217
Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis-a review, Med Mycol, vol.47, pp.387-397, 2009. ,
Characteristics of pathogenic fungi and antifungal therapy in cystic fibrosis, Expert Rev Anti Infect Ther, vol.8, pp.957-964, 2010. ,
Fungal infections and treatment in cystic fibrosis, Curr Opin Pulm Med, vol.19, pp.670-675, 2013. ,
DOI : 10.1097/mcp.0b013e328365ab74
Fungi in the cystic fibrosis lung: bystanders or pathogens?, Int J Biochem Cell Biol, vol.52, pp.161-173, 2014. ,
Pathogenesis of fungal infections in cystic fibrosis, Curr Fungal Infect Rep, vol.10, pp.163-169, 2016. ,
Lack of standardization in the procedures for mycological examination of sputum samples from CF patients: a possible cause for variations in the prevalence of filamentous fungi, Med Mycol, vol.48, pp.88-97, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-01118199
Update in cystic fibrosis, Am J Respir Crit Care Med, vol.173, pp.944-947, 2005. ,
Airway inflammation in cystic fibrosis, Chest, vol.133, pp.489-495, 2008. ,
Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis, J Infect Dis, vol.183, pp.444-452, 2001. ,
Group Consensus Study. Treatment of lung infection in patients with cystic fibrosis: current and future strategies, J Cyst Fibros, vol.11, pp.461-479, 2012. ,
Fungal respiratory infections in cystic fibrosis: a growing problem, Med Mycol, vol.48, pp.1-3, 2010. ,
Pathophysiology and management of pulmonary infections in cystic fibrosis, Am J Respir Crit Care Med, vol.168, pp.918-951, 2003. ,
Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis, J Cyst Fibros, vol.9, pp.110-116, 2010. ,
Genetic susceptibility to fungal infections: what is in the genes?, Curr Clin Microbiol Rep, vol.3, pp.81-91, 2016. ,
Genetic susceptibility to allergic bronchopulmonary aspergillosis in asthma: a genetic association study, Allergy Asthma Clin Immunol, vol.12, p.47, 2016. ,
Evidence for the involvement of two different MHC class II regions in susceptibility or protection in allergic bronchopulmonary aspergillosis, J Allergy Clin Immunol, vol.106, pp.723-729, 2000. ,
HLA-DRB1 and HLA-DQB1 genes on susceptibility to and protection from allergic bronchopulmonary aspergillosis in patients with cystic fibrosis, Microbiol Immunol, vol.57, pp.193-197, 2013. ,
Influence of interleukin-10 on Aspergillus fumigatus infection in patients with cystic fibrosis, J Infect Dis, vol.191, pp.1988-1991, 2005. ,
IL-4 alpha chain receptor (IL-4Ralpha) polymorphisms in allergic bronchopulmonary aspergillosis, Clin Mol Allergy, vol.4, p.3, 2006. ,
Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis, Infection, vol.15, pp.270-277, 1987. ,
Modified culture method detects a high diversity of fungal species in cystic fibrosis patients, Med Mycol, vol.52, pp.179-186, 2014. ,
Routine processing procedures for isolating filamentous fungi from respiratory sputum samples may underestimate fungal prevalence, Med Mycol, vol.50, pp.433-438, 2012. ,
DOI : 10.3109/13693786.2011.615762
URL : https://academic.oup.com/mmy/article-pdf/50/4/433/4002939/50-4-433.pdf
Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis, Mycoses, vol.46, pp.19-23, 2003. ,
Development of selective media for the isolation of yeasts and filamentous fungi from the sputum of adult patients with cystic fibrosis (CF), J Cyst Fibros, vol.7, pp.566-572, 2008. ,
Comparison of techniques to examine the diversity of fungi in adult patients with cystic fibrosis, Med Mycol, vol.48, pp.166-176, 2010. ,
Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis, Eur J Clin Microbiol Infect Dis, vol.19, pp.53-56, 2000. ,
Infections broncho-pulmonaires et mucoviscidose. Rémic, Référentiel en microbiologie médicale, 5` eméemé edition 2015, Société Française de Microbiologie, vol.5, issue.1, pp.193-200, 2015. ,
Compendium of Methods for the Microbiological Examination of Foods, 2001. ,
Dichloran-glycerol medium for enumeration of xerophilic fungi from low-moisture foods, Appl Environ Microbiol, vol.39, pp.488-492, 1980. ,
Comparison of an improved rose bengal-chlortetracycline agar with other media for the selective isolation and enumeration of moulds and yeasts in foods, J Appl Bacteriol, vol.36, pp.723-727, 1973. ,
Dichloran-rose bengal medium for enumeration and isolation of molds from foods, Appl Environ Microbiol, vol.37, pp.959-964, 1979. ,
The benomyl test as a fundamental diagnostic method for medical mycology, J Clin Microbiol, vol.31, pp.572-577, 1993. ,
Efficacy of a selective isolation procedure for members of the Pseudallescheria boydii complex, Antonie Van Leeuwenhoek, vol.93, pp.315-322, 2008. ,
Selective isolation of Pseudallescheria and Scedosporium species from respiratory tract specimens of cystic fibrosis patients, Respiration, vol.77, pp.320-324, 2009. ,
Detection of hyphomycetes in the upper respiratory tract of patients with cystic fibrosis, Mycoses, vol.54, pp.514-522, 2011. ,
Prevalence of Scedosporium species and Lomentospora prolificans in patients with cystic fibrosis in a multicenter trial by use of a selective medium, J Cyst Fibros, vol.14, pp.237-241, 2015. ,
Detection of occult Scedosporium species in respiratory tract specimens from patients with cystic fibrosis by use of selective media, J Clin Microbiol, vol.48, pp.314-316, 2010. ,
The nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for fungi, Proc Natl Acad Sci, vol.109, pp.6241-6246, 2012. ,
Population-based survey of filamentous fungi and antifungal resistance in Spain (FILPOP Study), Antimicrob Agents Chemother, vol.57, pp.3380-3387, 2013. ,
Molecular phylogeny of the Pseudallescheria boydii species complex: proposal of two new species, J Clin Microbiol, vol.43, pp.4930-4942, 2005. ,
Taxonomy and antifungal susceptibility of clinically important Rasamsonia species, J Clin Microbiol, vol.51, pp.22-30, 2013. ,
Applications of MALDI-TOF mass spectrometry in clinical diagnostic microbiology, FEMS Microbiol Rev, vol.36, pp.380-407, 2012. ,
Real-time identification of bacteria and Candida species in positive blood culture broths by matrix-assisted laser desorption ionization-time of flight mass spectrometry, J Clin Microbiol, vol.48, pp.1542-1548, 2010. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01405255
MALDI-TOF mass spectrometry in the clinical mycology laboratory: identification of fungi and beyond, Expert Rev Proteomics, vol.10, pp.151-164, 2013. ,
Discrimination of Penicillium isolates by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry fingerprinting, Rapid Commun Mass Spectrom, vol.22, pp.2555-2560, 2008. ,
Lass-Fï orl C et al. Species identification of ,
Fusarium and Mucorales with direct surface analysis by matrix-assisted laser desorption ionization time-of-flight mass spectrometry, Clin Microbiol Infect, vol.18, pp.475-484, 2012. ,
Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and accurate identification of Pseudallescheria/Scedosporium species, Clin Microbiol Infect, vol.20, pp.929-935, 2014. ,
Use of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of molds of the Fusarium genus, J Clin Microbiol, vol.53, pp.465-476, 2015. ,
Performance of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of Aspergillus, Scedosporium, and Fusarium spp. in the Australian clinical setting, J Clin Microbiol, vol.54, pp.2182-2186, 2016. ,
Mould routine identification in the clinical laboratory by matrix-assisted laser desorption ionization time-of-flight mass spectrometry, PloS One, vol.6, p.28425, 2011. ,
Development of a clinically comprehensive database and a simple procedure for identification of molds from solid media by matrix-assisted laser desorption ionization-time of flight mass spectrometry, J Clin Microbiol, vol.51, pp.828-834, 2013. ,
What can be learned from genotyping of fungi?, Med Mycol, vol.48, pp.60-69, 2010. ,
Genotyping of Scedosporium species: a review of molecular approaches, Med Mycol, vol.47, pp.406-414, 2009. ,
Phenotypic profiling of Scedosporium aurantiacum, an opportunistic pathogen colonizing human lungs, PLoS One, vol.10, p.122354, 2015. ,
DOI : 10.1371/journal.pone.0122354
URL : https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0122354&type=printable
,
, Multilocus sequence typing of Scedosporium apiospermum and Pseudallescheria boydii isolates from cystic fibrosis patients, J Cyst Fibros, vol.12, pp.592-598, 2013.
Semi-automated repetitive sequence-based PCR amplification for species of the Scedosporium apiospermum complex, Med Mycol, vol.54, pp.409-419, 2016. ,
Genotyping study of Scedosporium apiospermum isolates from patients with cystic fibrosis, J Clin Microbiol, vol.40, pp.2108-2114, 2002. ,
Highresolution genotyping of Aspergillus fumigatus isolates recovered from chronically colonised patients with cystic fibrosis, Eur J Clin Microbiol Infect Dis, vol.27, pp.1005-1007, 2008. ,
DOI : 10.1007/s10096-008-0527-1
URL : http://hdl.handle.net/1854/LU-481100
Different colonization patterns of Aspergillus terreus in patients with cystic fibrosis, Clin Microbiol Infect, vol.20, pp.327-333, 2014. ,
Long-term Rasamsonia argillacea complex species colonization revealed by PCR amplification of repetitive DNA sequences in cystic fibrosis patients, J Clin Microbiol, vol.54, pp.2804-2812, 2016. ,
Validation of a novel real-time PCR for detecting Rasamsonia argillacea species complex in respiratory secretions from cystic fibrosis patients, New Microbes New Infect, vol.2, pp.72-78, 2014. ,
Development of an oligonucleotide array for direct detection of fungi in sputum samples from patients with cystic fibrosis, J Clin Microbiol, vol.47, pp.142-152, 2009. ,
Use of denaturing highperformance liquid chromatography (DHPLC) to characterize the bacterial and fungal airway microbiota of cystic fibrosis patients, J Microbiol, vol.52, pp.307-314, 2014. ,
Cohort study of airway mycobiome in adult cystic fibrosis patients: differences in community structure between fungi and bacteria reveal predominance of transient fungal elements, J Clin Microbiol, vol.53, pp.2900-2907, 2015. ,
The airway microbiota in cystic fibrosis: a complex fungal and bacterial community-implications for therapeutic management, PloS One, vol.7, p.36313, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00806782
Characterization and quantification of the fungal microbiome in serial samples from individuals with cystic fibrosis, Microbiome, vol.2, p.40, 2014. ,
Investigation into the production of 2-pentylfuran by Aspergillus fumigatus and other respiratory pathogens in vitro and human breath samples, Med Mycol, vol.46, pp.209-215, 2008. ,
Detection of 2-pentylfuran in the breath of patients with Aspergillus fumigatus, Med Mycol, vol.47, pp.468-476, 2009. ,
Identification of Pseudomonas aeruginosa and Aspergillus fumigatus mono-and co-cultures based on volatile biomarker combinations, J Breath Res, vol.10, p.16002, 2016. ,
Hydroxamate siderophores of Scedosporium apiospermum, Biometals, vol.22, pp.1019-1029, 2009. ,
N(?)-methyl coprogen B, a potential marker of the airway colonization by Scedosporium apiospermum in patients with cystic fibrosis, Med Mycol, vol.48, pp.98-107, 2010. ,
Development and validation of an HPLC-MS/MS method for the early diagnosis of aspergillosis, PLoS One, vol.9, p.92851, 2014. ,
Bis(methyl)gliotoxin proves to be a more stable and reliable marker for invasive aspergillosis than gliotoxin and suitable for use in diagnosis, Diagn Microbiol Infect Dis, vol.73, pp.57-64, 2012. ,
Clinical validity of bis(methylthio)gliotoxin for the diagnosis of invasive aspergillosis, Appl Microbiol Biotechnol, vol.100, pp.2327-2334, 2016. ,
Novel immunologic classification of aspergillosis in adult cystic fibrosis, J Allergy Clin Immunol, vol.132, pp.560-566, 2013. ,
Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis, Cochrane Database Syst Rev, p.10288, 2013. ,
Serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis: state of the art and further challenges, Med Mycol, vol.48, pp.77-87, 2010. ,
Comparison of serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis, Eur Respir J, vol.31, pp.36-42, 2008. ,
Time course of antibody response to recombinant Aspergillus fumigatus antigens in cystic fibrosis with and without ABPA, Pediatr Allergy Immunol, vol.16, pp.217-225, 2005. ,
Recombinant allergens combined with biological markers in the diagnosis of allergic bronchopulmonary aspergillosis in cystic fibrosis patients. Clin Vaccine Immunol, vol.17, pp.1330-1336, 2010. ,
Blood basophil activation is a reliable biomarker of allergic bronchopulmonary aspergillosis in cystic fibrosis, Eur Respir J, vol.47, pp.177-185, 2016. ,
The role of basophil activation test in allergic bronchopulmonary aspergillosis and Aspergillus fumigatus sensitization in cystic fibrosis patients, J Cyst Fibros, vol.15, pp.587-596, 2016. ,
New commercially available IgG kits and Time-Resolved Fluorometric IgE assay for diagnosis of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis, Clin Vaccine Immunol, vol.23, pp.196-203, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01294619
Prospective evaluation of a new Aspergillus IgG enzyme immunoassay kit for diagnosis of chronic and allergic pulmonary aspergillosis, J Clin Microbiol, vol.54, pp.1236-1242, 2016. ,
Impact of Scedosporium apiospermum complex seroprevalence in patients with cystic fibrosis, J Cyst Fibros, vol.13, pp.667-673, 2014. ,
Purification and characterization of a mycelial catalase from Scedosporium boydii, a useful tool for specific antibody detection in patients with cystic fibrosis, Clin Vaccine Immunol, vol.22, pp.37-45, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01390731
Identification of Scedosporium boydii catalase A1 gene, a reactive oxygen species detoxification factor highly expressed in response to oxidative stress and phagocytic cells, Fungal Biol, vol.119, pp.1322-1333, 2015. ,
Hernando FL. Immunoproteomics-based analysis of the immunocompetent serological response to Lomentospora prolificans, J Proteome Res, vol.15, pp.595-607, 2016. ,
A 33 kDa serine proteinase from Scedosporium apiospermum, Biochem J, vol.315, pp.119-126, 1996. ,
Pseudallescheria boydii releases metallopeptidases capable of cleaving several proteinaceous compounds, Res Microbiol, vol.157, pp.425-432, 2006. ,
DOI : 10.1016/j.resmic.2005.11.010
Proteins and peptidases from conidia and mycelia of Scedosporium apiospermum strain HLPB, Mycopathologia, vol.167, pp.25-30, 2009. ,
DOI : 10.1007/s11046-008-9147-7
Molecular cloning and biochemical characterization of a Cu,Zn-superoxide dismutase from Scedosporium apiospermum, Microbes Infect, vol.9, pp.558-565, 2007. ,
Cell wall modifications during conidial maturation of the human pathogenic fungus Pseudallescheria boydii, PLoS One, vol.9, p.100290, 2014. ,
Draft genome sequence of the pathogenic fungus Scedosporium apiospermum, Genome Announc, vol.2, pp.988-1002, 2014. ,
Functional diversity of ankyrin repeats in microbial proteins, Trends Microbiol, vol.18, pp.132-129, 2010. ,
Draft genome of Australian environmental strain WM 09.24 of the opportunistic human pathogen Scedosporium aurantiacum, Genome Announc, vol.3, pp.1526-1540, 2015. ,
Draft genome sequence of the human pathogenic fungus Scedosporium boydii, Genome Announc, 2017. ,
Proteomics as a tool to identify new targets Aspergillus and Scedosporium in the context of cystic fibrosis, 2017. ,
A multifaceted study of Scedosporium boydii cell wall changes during germination and identification of GPI-anchored proteins, PLoS One, vol.10, p.128680, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01392256
New and improved techniques for the study of pathogenic fungi, Trends Microbiol, vol.24, pp.35-50, 2016. ,
Targeted disruption of melanin biosynthesis genes in the human pathogenic fungus Lomentospora prolificans and its consequences for pathogen survival, Int J Mol Sci, vol.17, p.444, 2016. ,
Genetic surgery in fungi: employing site-specific recombinases for genome manipulation, Appl Microbiol Biotechnol, vol.98, pp.1971-1982, 2014. ,
Illuminating fungal infections with bioluminescence, PLoS Pathog, vol.10, p.1004179, 2014. ,
DOI : 10.1371/journal.ppat.1004179
URL : https://hal.archives-ouvertes.fr/hal-01160160
Genome wide distribution of illegitimate recombination events in Kluyveromyces lactis, Nucleic Acids Res, vol.34, pp.1633-1645, 2006. ,
Tet-on, or Tet-off, that is the question: Advanced conditional gene expression in Aspergillus, Fungal Genet Biol, vol.89, pp.72-83, 2016. ,
Comparative in-vitro activity of voriconazole (UK109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum, J Antimicrob Chemother, vol.43, pp.149-151, 1999. ,
In vitro activities of four novel triazoles against Scedosporium spp, Antimicrob Agents Chemother, vol.45, pp.2151-2153, 2001. ,
, vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates, vol.46, pp.62-68, 2002.
DOI : 10.1128/aac.46.1.62-68.2002
URL : https://aac.asm.org/content/aac/46/1/62.full.pdf
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex, Antimicrob Agents Chemother, vol.50, pp.4211-4213, 2006. ,
In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species, Antimicrob Agents Chemother, vol.52, pp.1396-1400, 2008. ,
Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species. Antimicrob Agents Chemother, vol.56, pp.2635-2642, 2012. ,
Mucoviscidose et colonisation fongiquè a Scedosporium apiospermum. A propos de trois observations, J Mycol Méd, vol.1, pp.152-155, 1991. ,
European Society of Clinical Microbiology and Infectious Diseases Fungal Infection Study Group; European Confederation of Medical Mycology. ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others, Clin Microbiol Infect, vol.20, pp.27-46, 2014. ,
Infection and colonisation due to Scedosporium in Northern Spain. An in vitro antifungal susceptibility and molecular epidemiology study of 60 isolates, Mycoses, vol.54, pp.12-21, 2011. ,
In vitro activities of 35 double combinations of antifungal agents against Scedosporium apiospermum and Scedosporium prolificans, Antimicrob Agents Chemother, vol.52, pp.1136-1139, 2008. ,
Does a triple combination have better activity than double combinations against multiresistant fungi? Experimental in vitro evaluation, Int J Antimicrob Agents, vol.49, pp.422-426, 2017. ,
Infections caused by Scedosporium spp, Clin Microbiol Rev, vol.21, pp.157-197, 2008. ,
Combination chemotherapy for the treatment of invasive infections by Scedosporium prolificans, Clin Microbiol Infect, vol.6, pp.336-337, 2000. ,
In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates, Antimicrob Agents Chemother, vol.47, pp.106-117, 2003. ,
Effects of double and triple combinations of antifungal drugs in a murine model of disseminated infection by Scedosporium prolificans, Antimicrob Agents Chemother, vol.53, pp.2153-2155, 2009. ,
Nebulized voriconazole in infections with Scedosporium apiospermum-case report and review of the literature, J Cyst Fibros, vol.13, pp.400-402, 2014. ,
Scedosporium apiospermum: a fungal pathogen causing pneumonia in a patient with cystic fibrosis, JMM Case Rep, vol.2, 2015. ,
Acute Scedosporium apiospermum endobronchial infection in cystic fibrosis, Pediatr Infect Dis J, vol.35, pp.701-702, 2016. ,
Prospective multicenter German study on pulmonary colonization with Scedosporium /Lomentospora species in cystic fibrosis: Epidemiology and new association factors, PloS One, vol.12, p.171485, 2017. ,
Bilateral endogenous Scedosporium prolificans endophthalmitis after lung transplantation, Am J Ophthalmol, vol.139, pp.370-373, 2005. ,
Scedosporium apiospermum and S. prolificans mixed disseminated infection in a lung transplant recipient: An unusual case of long-term survival with combined systemic and local antifungal therapy in intensive care unit, Med Mycol Case Rep, vol.11, pp.53-56, 2016. ,
Disseminated Scedosporium apiospermum infection in a cystic fibrosis patient after double-lung transplantation, J Heart Lung Transplant, vol.25, pp.603-607, 2006. ,
Epidemiology of invasive mold infections in lung transplant recipients, Am J Transplant, vol.14, pp.1328-1333, 2014. ,
Chronic airway colonization by Scedosporium apiospermum with a fatal outcome in a patient with cystic fibrosis, Med Mycol, vol.48, pp.108-113, 2010. ,
Effective prolonged therapy with voriconazole in a lung transplant recipient with spondylodiscitis induced by Scedosporium apiospermum, Case Rep Infect Dis, p.460313, 2011. ,
Management of Scedosporium apiospermum in a pre-and post-lung transplant patient with cystic fibrosis, Med Mycol Case Rep, vol.2, pp.37-39, 2013. ,
Invasive Scedosporium sternal osteomyelitis following lung transplant: Cured, Med Mycol Case Rep, vol.12, pp.14-16, 2016. ,
DOI : 10.1016/j.mmcr.2016.07.001
URL : https://doi.org/10.1016/j.mmcr.2016.07.001
Multifocal Scedosporium apiospermum spondylitis in a cystic fibrosis patient, J Cyst Fibros, vol.7, pp.89-91, 2008. ,
DOI : 10.1016/j.jcf.2007.05.003
URL : https://doi.org/10.1016/j.jcf.2007.05.003
Breakthrough disseminated Scedosporium prolificans infection in a patient with relapsed leukemia on prolonged voriconazole followed by posaconazole prophylaxis, Mycopathologia, vol.166, pp.83-86, 2008. ,
Breakthrough lung Scedosporium prolificans infection with multiple cavity lesions in a patient receiving voriconazole for probable invasive aspergillosis associated with monoclonal gammopathy of undetermined significance (MGUS), Med Mycol J, vol.52, pp.33-38, 2011. ,
Scedosporium prolificans osteomyelitis in an immunocompetent child treated with a novel agent, hexadecylphospocholine (miltefosine), in combination with terbinafine and voriconazole: A case report, Clin Infect Dis, vol.48, pp.1257-1261, 2009. ,
Scedosporium prolificans osteomyelitis in an immunocompetent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanide, J Clin Microbiol, vol.41, pp.3981-3985, 2003. ,
DOI : 10.1128/jcm.41.8.3981-3985.2003
URL : https://jcm.asm.org/content/41/8/3981.full.pdf
Infective endocarditis caused by Scedosporium prolificans infection in a patient with acute myeloid leukemia undergoing induction chemotherapy, Int J Hematol, vol.101, pp.620-625, 2015. ,
Infective endocarditis and meningitis due to Scedosporium prolificans in a renal transplant recipient, J Infect Chemother, vol.20, pp.131-133, 2014. ,
Fatal fungemia with Scedosporium prolificans in a patient with acute myeloid leukemia, Med Mycol J, vol.55, pp.63-70, 2014. ,
Scedosporium prolificans brain abscess in a patient with chronic granulomatous disease: successful combination therapy with voriconazole and terbinafine, Scand J Infect Dis, vol.39, pp.87-90, 2007. ,
Cure of orthopaedic infection with Scedosporium prolificans, using voriconazole plus terbinafine, without the need for radical surgery, Mycoses, vol.46, pp.233-236, 2003. ,
Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine, Eur J Clin Microbiol Infect Dis, vol.22, pp.111-113, 2003. ,
Successful control of Scedosporium prolificans septic arthritis and probable osteomyelitis without radical surgery in a long-term renal transplant recipient, Transpl Infect Dis, vol.10, pp.63-65, 2008. ,
Bone and joint infection after traumatic implantation of Scedosporium prolificans treated with voriconazole and surgery, Acta Paediatr, vol.92, pp.980-982, 2003. ,
Breakthrough Scedosporium prolificans infection while receiving voriconazole prophylaxis in an allogeneic stem cell transplant recipient, Transpl Infect Dis, vol.9, pp.241-243, 2007. ,
DOI : 10.1111/j.1399-3062.2007.00203.x
In vitro antifungal activity of antipsychotic drugs and their combinations with conventional antifungals against Scedosporium and Pseudallescheria isolates, Med Mycol, vol.53, pp.890-895, 2015. ,
In vitro susceptibility of Scedosporium isolates to N-acetyl-L-cysteine alone and in combination with conventional antifungal agents, Med Mycol, vol.54, pp.776-779, 2016. ,
In vitro activity of miltefosine as a single agent and in combination with voriconazole or posaconazole against uncommon filamentous fungal pathogens, J Antimicrob Chemother, vol.68, pp.2842-2846, 2013. ,
Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods, Antimicrob Agents Chemother, vol.56, pp.352-357, 2012. ,
Dihydroorotate dehydrogenase inhibitor F901318 has potent in vitro activity against Scedosporium species and Lomentospora prolificans, J Antimicrob Chemother, 2017. ,
DOI : 10.1093/jac/dkx065
URL : https://academic.oup.com/jac/article-pdf/72/7/1977/17723356/dkx065.pdf
Chronic airway colonization by Penicillium emersonii in a patient with cystic fibrosis, Med Mycol, vol.37, pp.291-293, 1999. ,
Isolation of the fungus Geosmithia argillacea in sputum of people with cystic fibrosis, J Clin Microbiol, vol.48, pp.2615-2617, 2010. ,
Geosmithia argillacea: an emerging pathogen in patients with cystic fibrosis, J Clin Microbiol, vol.48, pp.2381-2386, 2010. ,
DOI : 10.1128/jcm.00047-10
URL : https://jcm.asm.org/content/48/7/2381.full.pdf
Clinical and microbiological efficacy of micafungin on Geosmithia argillacea infection in a cystic fibrosis patient, Med Mycol Case Rep, vol.1, pp.79-81, 2012. ,
Geosmithia argillacea: an emerging cause of invasive mycosis in human chronic granulomatous disease, Clin Infect Dis, vol.52, pp.136-143, 2011. ,
Emergence of disseminated infections due to Geosmithia argillacea in patients with chronic granulomatous disease receiving long-term azole antifungal prophylaxis, J Clin Microbiol, vol.49, pp.1681-1683, 2011. ,
Rasamsonia argillacea pulmonary and aortic graft infection in an immune-competent patient, J Clin Microbiol, vol.51, pp.719-722, 2013. ,
DOI : 10.1128/jcm.02884-12
URL : https://jcm.asm.org/content/51/2/719.full.pdf
Fatal disseminated Rasamsonia infection in cystic fibrosis post-lung transplantation, J Cyst Fibros, vol.16, pp.3-7, 2017. ,
DOI : 10.1016/j.jcf.2017.01.005
In vitro activity of isavuconazole against Rasamsonia species, Antimicrob Agents Chemother, vol.60, pp.6890-6891, 2016. ,
Infectious disease : how to bolster the antifungal pipeline, Science, vol.347, pp.1414-1416, 2015. ,
DOI : 10.1126/science.aaa6097
The anti-Aspergillus drug pipeline: Is the glass half full or empty?, Med Mycol, vol.55, pp.118-124, 2017. ,
DOI : 10.1093/mmy/myw060
URL : https://academic.oup.com/mmy/article-pdf/55/1/118/8560093/myw060.pdf
The antifungal pipeline: a reality check, Nat Rev Drug Discov, vol.16, pp.603-616, 2017. ,
DOI : 10.1038/nrd.2017.46
URL : http://europepmc.org/articles/pmc5760994?pdf=render
InterProScan 5: genome-scale protein function classification, Bioinformatics, vol.30, pp.1236-1276, 2014. ,
DOI : 10.1093/bioinformatics/btu031
URL : https://academic.oup.com/bioinformatics/article-pdf/30/9/1236/653449/btu031.pdf
Rafael CantónCant´Cantón, Nina Gunde-Cimerman (Ljubljana, Slovenia), ¨ Ozge G ¨ ungörung¨ungör ,